Prim, S.A. (BME:PRM)
13.40
+0.05 (0.37%)
Apr 28, 2026, 11:53 AM CET
Prim, S.A. Revenue
In the year 2025, Prim, S.A. had annual revenue of 251.89M EUR with 7.94% growth. Prim, S.A. had revenue of 124.88M in the half year ending December 31, 2025, with 15.77% growth.
Revenue
251.89M
Revenue Growth
+7.94%
P/S Ratio
0.90
Revenue / Employee
255.99K
Employees
984
Market Cap
227.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 251.89M | 18.54M | 7.94% |
| Dec 31, 2024 | 233.36M | 16.74M | 7.73% |
| Dec 31, 2023 | 216.62M | 19.22M | 9.74% |
| Dec 31, 2022 | 197.40M | 28.82M | 17.10% |
| Dec 31, 2021 | 168.57M | 21.16M | 14.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Almirall | 1.11B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Laboratorio Reig Jofre | 336.68M |
| Clínica Baviera | 304.91M |
| Pharma Mar | 221.39M |
| Atrys Health | 144.31M |
| Labiana Health | 71.67M |